CGON
Price
$33.07
Change
+$2.13 (+6.88%)
Updated
Sep 5 closing price
Capitalization
2.36B
73 days until earnings call
CRIS
Price
$1.68
Change
-$0.03 (-1.75%)
Updated
Sep 5 closing price
Capitalization
21M
Interact to see
Advertisement

CGON vs CRIS

Header iconCGON vs CRIS Comparison
Open Charts CGON vs CRISBanner chart's image
CG Oncology
Price$33.07
Change+$2.13 (+6.88%)
Volume$2.02M
Capitalization2.36B
Curis
Price$1.68
Change-$0.03 (-1.75%)
Volume$65.72K
Capitalization21M
CGON vs CRIS Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. CRIS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and CRIS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CGON: $33.07 vs. CRIS: $1.68)
Brand notoriety: CGON and CRIS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 257% vs. CRIS: 55%
Market capitalization -- CGON: $2.36B vs. CRIS: $21M
CGON [@Biotechnology] is valued at $2.36B. CRIS’s [@Biotechnology] market capitalization is $21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileCRIS’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • CRIS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGON is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while CRIS’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 5 bearish.
  • CRIS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +23.30% price change this week, while CRIS (@Biotechnology) price change was +0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CGON is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.36B) has a higher market cap than CRIS($21M). CGON YTD gains are higher at: 15.307 vs. CRIS (-45.098). CRIS has higher annual earnings (EBITDA): -36.02M vs. CGON (-157.09M). CGON has more cash in the bank: 661M vs. CRIS (10.1M). CGON has less debt than CRIS: CGON (994K) vs CRIS (2.31M). CRIS has higher revenues than CGON: CRIS (11.4M) vs CGON (551K).
CGONCRISCGON / CRIS
Capitalization2.36B21M11,233%
EBITDA-157.09M-36.02M436%
Gain YTD15.307-45.098-34%
P/E RatioN/AN/A-
Revenue551K11.4M5%
Total Cash661M10.1M6,545%
Total Debt994K2.31M43%
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONCRIS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 16 days ago
75%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TCRAX59.74N/A
N/A
American Century Growth A
CEVZX13.97N/A
N/A
Columbia Global Value Inst
ISMSX9.92N/A
N/A
VY® American Century Sm-Mid Cp Val S2
HFYCX12.86N/A
N/A
Hartford Schroders Intl Multi-Cp Val C
LAFLX15.03N/A
N/A
Lord Abbett Focused Large Cap Value A

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+6.88%
SYRE - CGON
61%
Loosely correlated
+0.06%
IDYA - CGON
60%
Loosely correlated
+5.15%
ACLX - CGON
56%
Loosely correlated
+0.64%
CRNX - CGON
55%
Loosely correlated
+3.97%
KYMR - CGON
55%
Loosely correlated
+3.10%
More